Whataburger sued by customer alleging onions on burger caused 'allergic reaction'
Whataburger sued by customer alleging onions on burger caused 'allergic reaction' A Houston man is seeking monetary relief of more than $250,000 after suffering 'serious personal injuries,' claiming he had an 'allergic reaction' when onions were not left off the burger he ordered.
Show Caption
Hide Caption
How to make burgers in bulk
Make delicious, juicy burgers for larger crowds with this hack.
Problem Solved
Special orders at a fast-food restaurant do not usually come up in a lawsuit, but one Houston man has a beef with a particular burger chain.
Demery Ardell Wilson is suing Whataburger after he got an "allergic reaction" due to onions being present on his burger after he requested the vegetables not be added, according to the petition obtained by USA TODAY. The incident occurred on July 24, 2024, at an unidentified Whataburger location, the court document says.
Due to the allergic reaction caused by the onions, Wilson suffered "serious personal injuries," for which "he had to seek the care of medical professionals," the petition states. He is seeking monetary relief of over $250,000, but less than $1 million, the court document continues.
Whataburger denied Wilson's allegations in a separate court document filed on May 16, and demanded "strict proof" of his assertations. The San Antonio, Texas-headquartered chain also claims it did not know, nor should have known, any product purchased by Wilson "was in a defective or unreasonably dangerous condition at the time."
USA TODAY contacted Whataburger on May 17 but has not received a response.
Wilson also sued Sonic Drive-In for adding onions to burger
Whataburger is not the only fast food chain Wilson has sued over onions. He also previously filed a lawsuit against Sonic Drive-In.
According to the petition, Wilson picked up a burger on April 14, 2023, from a Sonic Drive-In in Cypress, an area 24 miles northwest of downtown Houston. Like the alleged incident at Whataburger, Wilson said he requested no onions on his burger, the court document states.
The onions on the burger caused Wilson to "feel sick," the petition says. This incident also left Wilson with "serious personal injuries" that caused him to seek the care of medical professionals.
Sonic Drive-In denied Wilson's allegations in a court document filed on May 12, saying that he should "be required to prove the charges and allegations" against them.
USA TODAY contacted Sonic Drive-In about the as-yet-unresolved suit on May 17 but has not received a response.
Jonathan Limehouse covers breaking and trending news for USA TODAY. Reach him at JLimehouse@gannett.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
32 minutes ago
- Wall Street Journal
This Conservative Is Doing Just Fine, Thank You, After Getting Dumped by Trump
'House of David,' a retelling of the biblical shepherd's unlikely rise, capped season one with the future king's epic takedown of Goliath and started April in Amazon's top streaming spot. David's surprise triumph was also Leonard Leo's. The conservative lawyer and co-chairman of the Federalist Society has been secretly helping bankroll Wonder Project, a Texas-based studio that produced the popular series and, Leo hopes, will follow with a string of Christian- and conservative-leaning shows so slick they can go head-to-head with other big-budget entertainment.
Miami Herald
33 minutes ago
- Miami Herald
Major healthcare business files for Chapter 11 bankruptcy
Biotechnology companies often encounter common challenges of long timelines for developing their products, the high costs associated with creating their innovations, and regulatory problems that must be solved to bring their inventions to market. Companies will amass huge amounts of debt over the years that's needed to develop medical devices, drugs, and other products, which can lead to financial distress and sometimes bankruptcy filings. Don't miss the move: Subscribe to TheStreet's free daily newsletter Over a 12-year period from 2011 through 2022, biotech firms filed fewer than 10 bankruptcies each year, but that changed beginning in 2023. Related: Key healthcare company files for Chapter 11 bankruptcy Biotech firms filed 14 cases in 2023, which was the highest number since 2010, when 14 firms filed for bankruptcy. Companies filed 13 petitions in 2024. Economic issues common to all businesses, such as rising costs of labor and products driven by inflation and rising inflation, played a role in distress over the last two years. AmplifyBio, which develops next-generation vaccines, medicine, and therapeutics, filed for Chapter 11 protection on May 17, 2025, seeking to sell all of its assets and liquidate through the bankruptcy process. The debtor's largest creditors included certain shareholders, including Battelle Services Co., owed $3.25 million; Battelle Memorial Institute, owed $1.89 million; and Kavra 14 LLC, owed $1.8 million. Distressed biotechnology company Synthego Corp. filed for Chapter 11 bankruptcy protection on May 5, seeking to sell its assets to its prepetition lender Perceptive Credit Holdings III L.P. in a bankruptcy sale with a stalking-horse bid calling for a credit bid of $74.4 million of debt owed to the lender, as well as a $12.5 million DIP financing. Austin, Texas-based biotechnology company Molecular Templates Inc., which develops cancer treatment drugs, filed for Chapter 11 bankruptcy on April 20, 2025, with plans to hand its assets to its secured lender as part of a restructuring support agreement. And now, medical diagnostics company Capture Collective Inc., which is developing and commercializing medical testing equipment for early detection of radiation exposure, and two affiliates, filed for Chapter 11 bankruptcy protection on May 27 to reorganize their debts, facing high litigation costs. Related: Major health care company files for bankruptcy to sell assets The company listed $1 million to $10 million in assets and liabilities in its petition filed in the U.S. Bankruptcy Court for the Southern District of Ohio, including a $5.7 million disputed tax claim owed to its largest creditor Hawaii Department of Taxation. More bankruptcy: Iconic auto repair chain franchise files Chapter 11 bankruptcyPopular beer brand closes down and files Chapter 7 bankruptcyPopular vodka and gin brand files for Chapter 11 bankruptcy The Columbus, Ohio-based debtor and affiliates Capture Diagnostics LLC and Capture Diagnostics HIB01 had also faced costly contract disputes as a result of its Covid-19 testing business that ceased operations in May 2023. Capture Collective was unable to resolve the contract disputes with claimants after the Covid-19 testing business ended. The company said high litigation costs had exhausted all of its remaining capital resources and made it impossible for the company to obtain new venture capital, according to information provided by RK Consultants. All litigation filed against Capture Collective and its affiliates is subject to an automatic stay while the bankruptcy case proceeds. Capture Collective is developing the radiation biodosimetry diagnostic test, MiRAD, a high-throughput, microRNA biomarker-based biodosimetry assay, which enables individualized clinical biomarker quantification in direct correlation with radiation exposure. Related: Another major healthcare company files Chapter 11 bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Wall Street Journal
an hour ago
- Wall Street Journal
Musk Says SpaceX Revenue Will Near $16 Billion in 2025
SpaceX is on track to record another significant revenue increase this year, Elon Musk said, continuing a growth streak at the world's busiest rocket launcher. Musk, SpaceX's chief executive, said Tuesday on X that the Texas-based company is expected to generate about $15.5 billion in revenue in 2025. Privately held since Musk founded it in 2002, SpaceX doesn't publicly disclose its financial results, making information about its performance rare. In 2022, SpaceX's annual revenue totaled $4.6 billion, The Wall Street Journal has reported. Late last year, SpaceX was valued at $350 billion. The company has two main business lines that have stoked revenue growth in recent years. One is its launch operation, which revolves around its Falcon 9 rocket. The partially reusable vehicle has emerged as the global workhorse, frequently used for U.S. government missions and by private satellite operators. SpaceX's launch business has been helped by the company's focus on reusability, as well technical problems that have delayed several competing rockets. The company's other major business is Starlink—a low-Earth-orbit satellite constellation that provides subscribers on the ground with high-speed internet connections. Starlink has driven a major part of the recent revenue gains at SpaceX, according to analysts tracking the company. Quilty Space, a consulting firm, estimates Starlink revenue is set to grow to $12.3 billion this year from $7.8 billion in 2024. Starlink has won household subscribers from competing satellite services, built up a growing government business and reeled in blue-chip corporate clients, like United Airlines and Deere. SpaceX continues to invest heavily in vehicle development and infrastructure efforts. A good part of its cash is flowing toward Starship, the deep-space vehicle the company has been testing in flight since 2023 and hopes to one day use for missions to Mars. Bret Johnsen, finance chief at SpaceX, said at an industry event in March that getting Starship prepared for Mars was a huge endeavor. He said SpaceX continued to spend its own funds on research and development for the roughly 400-foot-tall vehicle, which the company has called the most powerful rocket ever built. In his post Tuesday, Musk said 'commercial revenue' at SpaceX would exceed the entire budget of NASA next year. The White House, where Musk worked until recently, has proposed cutting the National Aeronautics and Space Administration budget to $18.8 billion for its next fiscal year from nearly $25 billion currently. NASA's funds flow to a far-reaching set of scientific and exploration endeavors, and SpaceX is a major contractor at the agency. Musk said about $1.1 billion of the company's expected revenue this year would come from NASA. Write to Micah Maidenberg at and Dean Seal at
